Harvey M. Friedman

Infectious Disease
3400 Spruce St
Philadelphia, PA 19104

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 68 publications

Bispecific antibodies targeting herpes simplex virus glycoproteins B and D.

Bispecific antibodies targeting herpes simplex virus glycoproteins B and D.

Journal: Frontiers in immunology
Published: February 03, 2026

Immunogenicity and Efficacy of a Trivalent HSV-2 gC2, gD2, gE2 Nucleoside-Modified mRNA-LNP Vaccine Against HSV-1 Eye Infection and Neuroinvasion in Mice.

Immunogenicity and Efficacy of a Trivalent HSV-2 gC2, gD2, gE2 Nucleoside-Modified mRNA-LNP Vaccine Against HSV-1 Eye Infection and Neuroinvasion in Mice.

Journal: Vaccines
Published: January 09, 2026

HSV-2 gC2 mRNA immunization in mice protects by producing antibodies that bind immune evasion epitopes.

HSV-2 gC2 mRNA immunization in mice protects by producing antibodies that bind immune evasion epitopes.

Journal: PLoS pathogens
Published: January 08, 2026

HSV-2 gE2/gI2 are immune evasion molecules that bind IgG Fc to inhibit antibody-dependent cellular cytotoxicity.

HSV-2 gE2/gI2 are immune evasion molecules that bind IgG Fc to inhibit antibody-dependent cellular cytotoxicity.

Journal: Frontiers in immunology
Published: December 12, 2025

Unveiling the unique interaction mechanism of herpes simplex virus 2 glycoprotein C with C3b.

Unveiling the unique interaction mechanism of herpes simplex virus 2 glycoprotein C with C3b.

Journal: bioRxiv : the preprint server for biology
Published: November 19, 2025

Seroconversion Is Misleading as a Test for HSV-2 Infection in Prophylactic Genital Herpes Vaccine Trials: Results of Vaccine Studies in Guinea Pigs.

Seroconversion Is Misleading as a Test for HSV-2 Infection in Prophylactic Genital Herpes Vaccine Trials: Results of Vaccine Studies in Guinea Pigs.

Journal: Viruses
Published: May 07, 2025

Targeting Herpes Simplex Virus Glycoprotein D with Bispecific Antibodies: Expanding Therapeutic Horizons by Searching for Synergy.

Targeting Herpes Simplex Virus Glycoprotein D with Bispecific Antibodies: Expanding Therapeutic Horizons by Searching for Synergy.

Journal: Viruses
Published: January 08, 2025

Prevalence of Aortic Root Pathologies in Platypnea-Orthodeoxia Syndrome Secondary to Intra-Cardiac Shunts.

Prevalence of Aortic Root Pathologies in Platypnea-Orthodeoxia Syndrome Secondary to Intra-Cardiac Shunts.

Journal: Cardiology research
Published: February 06, 2024

Rapid and accurate detection of herpes simplex virus type 2 using a low-cost electrochemical biosensor.

Rapid and accurate detection of herpes simplex virus type 2 using a low-cost electrochemical biosensor.

Journal: Cell reports. Physical science
Published: January 19, 2024

A Trivalent HSV-2 gC2, gD2, gE2 Nucleoside-Modified mRNA-LNP Vaccine Provides Outstanding Protection in Mice against Genital and Non-Genital HSV-1 Infection, Comparable to the Same Antigens Derived from HSV-1.

A Trivalent HSV-2 gC2, gD2, gE2 Nucleoside-Modified mRNA-LNP Vaccine Provides Outstanding Protection in Mice against Genital and Non-Genital HSV-1 Infection, Comparable to the Same Antigens Derived from HSV-1.

Journal: Viruses
Published: June 10, 2023

A Case Series of Non-Tuberculous Mycobacterial Pulmonary Disease Masquerading as Malignancy From a Community-Based Hospital.

A Case Series of Non-Tuberculous Mycobacterial Pulmonary Disease Masquerading as Malignancy From a Community-Based Hospital.

Journal: Journal of medical cases
Published: April 10, 2023

Novel Adjuvant S-540956 Targets Lymph Nodes and Reduces Genital Recurrences and Vaginal Shedding of HSV-2 DNA When Administered with HSV-2 Glycoprotein D as a Therapeutic Vaccine in Guinea Pigs.

Novel Adjuvant S-540956 Targets Lymph Nodes and Reduces Genital Recurrences and Vaginal Shedding of HSV-2 DNA When Administered with HSV-2 Glycoprotein D as a Therapeutic Vaccine in Guinea Pigs.

Journal: Viruses
Published: April 01, 2023
Showing 1-12 of 68

Last Updated: 09/26/2026